Immunogenicity of Conjugates of Protective Antigen Complexes of Tularemia Microbe with Gold Nanoparticles
- 9 Downloads
Conjugates of gold nanoparticles with two isolated tularemia microbe antigens, a protective antigen complex and a glycosylated protein complex, are used to obtain anti-tularemia sera and to vaccinate animals. A conjugate of gold nanoparticles with the glycosylated protein complex during the subcutaneous immunization of mice is more effective than the unconjugated antigen, which is evident from the increase in protectiveness and antibody titers. The use of conjugates of both antigens with gold nanoparticles during the immunization of rabbits makes it possible to obtain sera with a high titer of specific antibodies (1/64–1/128 titer in the diffusion precipitation reaction and 1/5120–1/10240 in the reaction of indirect hemagglutination) during a relatively short period of time and with minimal antigen consumption (1.8–10 mg). The use of immunoglobulins extracted from sera during the enzyme-linked immunosorbent assay makes it possible to detect Francisella tularensis cells of different subspecies in the amount of (5.2 ± 0.5) × 105 MC/mL with 100% specificity for heterologous strains at a concentration of 108 MC/mL, which enables their subsequent application in the production of preparations for the diagnostics of tularemia.
Unable to display preview. Download preview PDF.
- 2.T. Y. Kudryavtseva, D. V. Trankvilevsky, A. N. Mokrievich, V. P. Popov, N. S. Morozova, M. V. Zarochentsev, A. V. Mazepa, L. P. Okunev, A. V. Kholin, S. A. Kosilko, Y. M. Fedorov, M. V. Khramov, and I. A. Dyatlov, “Epizootic and epidemic situation on tularemia in the russian federation in 2015 and prognosis for 2016,” Probl. Osobo Opasn. Infekts., No. 1, 28–32 (2016).CrossRefGoogle Scholar
- 4.R. Sunagar, S. Kumar, B. J. Franz, and E. J. Gosselin, “Tularemia vaccine development: paralysis or progress?,” Vaccine (Auckl.) 2016 (6), 9–23 (2016).Google Scholar
- 6.G. G. Onishchenko and V. V. Kutyrev, Laboratory Diagnosis of Dangerous Infectious Diseases: A Practical Guide (Shiko, Moscow, 2013) [in Russian].Google Scholar
- 17.E. M. Kuznetsova, O. A. Volokh, I. A. Shepelev, and A. K. Nikiforov, “The components of francisella tularensis protective antigene complex,” Mol. Genet., Mikrobiol. Virusol., No. 3, 22–25 (2012).Google Scholar
- 18.E. M. Kuznetsova, O. A. Volokh, I. A. Shepelev, and N. G. Avdeeva, “Glycosylated protein complex francisella tularensis,” in Innovative Technologies in Anti-Epidemic Protection of the Population, Ed. by E. I. Efimov (Areal, Nizh. Novgorod, 2011), pp. 93–95 [in Russian].Google Scholar
- 20.W. Geoghegan and G. Ackerman, “Adsorption of horseradish peroxidase, ovomucoid and anti-immunoglobulin to colloidal gold for the indirect detection od concanavalin a, wheat germ agglutinin and goat antihuman immunoglobuli G on cell surfaces at the electron microscopic level: a new method, theory and application,” J. Histochem. Cytochem. 25, 1187–1200 (1977).CrossRefGoogle Scholar
- 21.A. I. Karpishchenko, Medical Laboratory Technologies: A Guide to Clinical Laboratory Diagnostics (GOETARMedia, Moscow, 2012) [in Russian].Google Scholar
- 22.S. Glants, Biomedical Statistics (Praktika, Moscow, 1998) [in Russian].Google Scholar
- 23.V. S. Khlebnikov, I. R. Golovlev, D. P. Kulevatskii, S. F. Averin, S. Yu. Pshirkov, N. V. Tokhtamysheva, V. E. Zhemchugov, L. A. Safonova, V. N. Gerasimov, A. M. Chugunov, S. S. Vetchinin, V. G. Galaktionov, and S. S. Afanas’ev, “Biochemical, antigenic and protective properties of the outer membrane of tularemia pathogens,” Mol. Genet., Mikrobiol. Virusol., No. 7, 15–20 (1991).Google Scholar
- 25.A. N. Somov, T. B. Kravchenko, V. M. Pavlov, G. M. Vakhrameeva, T. I. Kombarova, R. I. Mironova, V. V. Firstova, O. V. Kalmantaeva, S. S. Vetchinin, and A. N. Mokrievich, “Antigenic and immunogenic characteristics of dissolved, adsorbed and microencapsulated formulations of acid-insoluble complex from Francisella tularensis 15 NIIG strain,” Biotekhnologiya 33 (5), 23–34 (2017).CrossRefGoogle Scholar
- 29.L. C.-W. Lin, S. Chattopadhyay, J. C. Lin, C. M. J. Hu, “Advances and opportunities in nanoparticle-and nanomaterials-based vaccines against bacterial infections,” Adv. Healthcare Mater. 7, e1701395 (2018).Google Scholar